Cardiovascular disease remains the principal cause of death and disability among patients
with diabetes mellitus. Diabetes mellitus exacerbates mechanisms underlying …

Cardio-metabolic disease, namely ischemic heart disease, stroke, obesity, and type 2
diabetes, represent substantial health and economic burdens. Almost one half of cardio …

Adherence to therapy is defined as the extent to which a person's behavior in taking
medication, following a diet, and/or executing lifestyle changes, corresponds with agreed …

Abstract Cardiovascular (CV) disease (CVD) is the leading global cause of mortality, being
responsible for 46% of non-communicable disease deaths. It has been estimated that about …

OBJECTIVE To assess the efficacy and safety of 32 mg naltrexone sustained-release
(SR)/360 mg bupropion SR (NB) in overweight/obese individuals with type 2 diabetes with …

Importance There is substantial uncertainty about optimal glycemic control in older adults
with type 2 diabetes mellitus. Observations Four large randomized clinical trials (RCTs) …

Background & aims To update the European Association for the Study of Diabetes (EASD)
clinical practice guidelines for nutrition therapy, we conducted a systematic review and meta …

Background Patients with type 2 diabetes mellitus (T2D) have an increased risk of
cardiovascular disease and mortality compared to the background population …

Objective To assess the effect of targeting intensive glycaemic control versus conventional
glycaemic control on all cause mortality and cardiovascular mortality, non-fatal myocardial …

Aim: Some studies suggested that metformin could reduce cardiovascular risk to a greater
extent than that determined by glucose reduction. Aim of the present meta‐analysis is to …